Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Vencarb Plus is an ophthalmic lubricant formulation developed by Venistro Biotech. It is a combination of carboxymethylcellulose sodium and glycerin (glycerol), used primarily for the symptomatic relief of dry eye syndrome and ocular irritation. Carboxymethylcellulose acts as a viscosity-increasing agent that prolongs the retention time of the lubricant on the ocular surface, while glycerin serves as a humectant and osmoprotectant, helping to hydrate the corneal epithelium and stabilize the tear film. The product is marketed for ophthalmic use to provide long-lasting relief from dryness, burning, and discomfort caused by environmental factors or decreased tear production.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on carboxymethylcellulose sodium + glycerin (Venistro Biotech).